Zhongchao Inc

ZCMDHealthcare·Health Information Services·China·Nano·NASD·Nov 11 • 3:59 PM ET

0.9752+0.0133 (1.38%)

2026-11-12 00:41 CET

Market cap

4.27 USD m

Revenue, TTM

6.61 USD m

Net income, TTM

-10.64 USD m

Free cash flow, TTM

-2.66 USD m

EPS diluted, TTM

-383.15

P/E

Compare

Price

ZCMD against its 20, 50 and 200-day averages

2050200

99.9% under the 52-week high of 1,443.36 on 4 Feb 2026. 52-week low 0.87 on 3 Nov 2026. Last 15 sessions, 58.0% high to low

Volume 0.07× normal · the line is the 50-bar volume average

Profile

ZCMD

52-week range, 0% of the way up

0.871,443

Zhongchao, Inc. is a holding company, which engages in the provision of healthcare information, education, and training services. It operates under the Services and Drugs segments. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, articles, and short videos with educational healthcare content to healthcare professionals as well as the public. The company was founded by Wei Guang Yang on August 17, 2012 and is headquartered in Shanghai, China.

Employees	33
IPO	Feb 24, 2020
Beta	-0.00
ATR, 14d	0.13
Rel volume	0.07
Short float	1.34%
Insider own	30.53%
Inst own	0.26%

Snapshot

6 groups

Valuation

Index	-
Market Cap	4.33M
Enterprise Value	-9.07M
Income	-10.64M
Sales	6.61M
Book/sh	72.70
Cash/sh	3.91
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	33
IPO	Feb 24, 2020

Ratios

P/E	-
Forward P/E	-
PEG	-
P/S	0.65
P/B	0.01
P/C	0.25
P/FCF	-
EV/EBITDA	-
EV/Sales	-1.37
Quick Ratio	43.35
Current Ratio	43.35
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

Earnings

EPS (ttm)	-383.15
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	41.13% -
Sales past 3/5Y	-7.02% -8.76%
EPS Y/Y TTM	-31.56%
Sales Y/Y TTM	-49.58%
EPS Q/Q	-70.34%
Sales Q/Q	-85.00%
Earnings	-
EPS/Sales Surpr.	- -

Ownership

Insider Own	30.53%
Insider Trans	0.00%
Inst Own	0.26%
Inst Trans	-11.13%
ROA	-41.05%
ROE	-51.41%
ROIC	-50.35%
Gross Margin	35.27%
Oper. Margin	-147.09%
Profit Margin	-160.90%
SMA20	-13.82%
SMA50	-33.43%
SMA200	-99.36%
Trades	-

Technical

Shs Outstand	4.44M
Shs Float	3.08M
Short Float	1.34%
Short Ratio	0.07
Short Interest	0.04M
52W High	1443.36 -99.93%
52W Low	0.87 12.52%
Volatility	8.47% 8.84%
ATR (14)	0.13
RSI (14)	32.22
Beta	-0.00
Rel Volume	0.07
Avg Volume	604.40K
Volume	41,700

Performance

Perf Week	1.36%
Perf Month	-24.98%
Perf Quarter	-52.66%
Perf Half Y	-99.65%
Perf YTD	-99.85%
Perf Year	-99.91%
Perf 3Y	-99.99%
Perf 5Y	-100.00%
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	0.96
Price	0.98
Change %	1.38%

Peers

Mkt cap

Ticker	Company	Mkt cap
DOCS	Doximity Inc	5.92B
POM	Pomdoctor Ltd	13.84M
HSTM	Healthstream Inc	884.68M
OPRX	OptimizeRx Corp	168.59M
SY	So-Young International Inc ADR	179.37M
MNDR	Mobile health Network Solutions	1.15M
HCTI	Healthcare Triangle Inc	3.89M
YI	111 Inc ADR	15.21M
CCM	Concord Medical Services ADR	9.81M
BNR	Burning Rock Biotech Ltd ADR	116.38M

Ticker

Company

Mkt cap

DOCS

Doximity Inc

5.92B

POM

Pomdoctor Ltd

13.84M

HSTM

Healthstream Inc

884.68M

OPRX

OptimizeRx Corp

168.59M

So-Young International Inc ADR

179.37M

MNDR

Mobile health Network Solutions

1.15M

HCTI

Healthcare Triangle Inc

3.89M

111 Inc ADR

15.21M

CCM

Concord Medical Services ADR

9.81M

BNR

Burning Rock Biotech Ltd ADR

116.38M

News

latest 14 of 158

Sep-30-26 08:00AMZhongchao Inc. Announces 1-for-2 Share Consolidation (PR Newswire)
Jul-23-26 09:00AMZhongchao Inc. Announces $5.0 Million Registered Direct Offering (PR Newswire) -59.67%
Jun-25-26 08:00AMZhongchao Inc. Announces 1-for-3 Share Consolidation (PR Newswire) -11.22%
Jun-04-26 08:00AMZhongchao Inc. Announces 1-for-31 Share Consolidation (PR Newswire) -32.96%
May-29-26 10:00AMZhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering (PR Newswire) -69.09%
Feb-26-26 08:30AMZhongchao Inc. Announces 1-for-8 Share Consolidation (PR Newswire) -10.68%
Apr-19-24 08:27AMWhy Is Zhongchao (ZCMD) Stock Up 103% Today? (InvestorPlace) +33.79%
Apr-04-24 08:12AMWhy Is Zhongchao (ZCMD) Stock Up 40% Today? (InvestorPlace) +24.68%
Mar-12-24 08:30AMZhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications (PR Newswire) +13.16%
Mar-05-24 07:54AMWhy Is Zhongchao (ZCMD) Stock Up 15% Today? (InvestorPlace) -17.30%
Feb-27-24 08:00AMZhongchao Inc. Announces 1-for-10 Share Consolidation (PR Newswire) +12.89%
Dec-11-23 08:00AMZhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments (PR Newswire) -31.03%
Oct-23-23 08:00AMZhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day (PR Newswire)
Sep-25-23 08:00AMZhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients (PR Newswire)

Key figures

Revenue, TTM	6.61
Net income, TTM	-10.64
EPS diluted, TTM	-383.15
EBIT, TTM	-9.73
Free cash flow, TTM	-2.66
Gross margin	35.27%
Operating margin	-147.09%
Net margin	-160.90%
Market cap	4.27
P/E	-
Sales Y/Y, TTM	-49.58%

USD millions. TTM from the statement feed.

Quarterly earnings

actual against estimate

Period	Reported	EPS act	EPS est	EPS rep	Sales act	Sales est	Analysts
No quarterly earnings.

Period

Reported

EPS act

EPS est

EPS rep

Sales act

Sales est

Analysts

No quarterly earnings.

Annual earnings

Period	EPS act	EPS est	EPS rep	Sales act	Sales est
No annual earnings.

Period

EPS act

EPS est

EPS rep

Sales act

Sales est

No annual earnings.

Estimate revisions

last 14 periods

Period	Type	Date	Estimates	Up	Down	Mean	Low	High
No estimate revisions.

Period

Type

Date

Estimates

Down

Mean

Low

High

No estimate revisions.

Estimate history

Period	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS, annual	908.424	1793.486	2349.849	2660.692	142.402	-1683.225	-6479.197	-183.872	-343.356
EPS, quarterly
Period
Sales, annual	9.816	12.866	14.883	17.99	16.297	14.152	19.434	15.865	11.375
Period	2017	2018	2019	2020	2021	2022	2023	2024	2025
Sales, quarterly
Period
Shares, annual	0.002	0.002	0.002	0.002	0.002	0.002	0.002	0.017	0.021
Period	2017	2018	2019	2020	2021	2022	2023	2024	2025
Shares, quarterly
Period

Income statement, annual

Currency USD, millions
Metric	TTM	2025FY	2024FY	2023FY	2022FY	2021FY	2020FY	2019FY	2018FY
Total Revenue	6.61	11.37	15.86	19.43	14.15	16.30	17.99	14.88	12.87
Cost of Goods Sold Incl. D&A	4.28	6.54	6.95	10.92	7.79	6.86	6.12	4.66	4.46
Gross Profit	2.33	4.83	8.91	8.51	6.36	9.44	11.87	10.23	8.41
Selling, General and Administrative Excl. Other	12.06	11.02	9.25	13.92	9.31	9.76	7.38	6.58	5.13
Research and Development	0.00	0.01	0.25	0.51	0.41	0.76	0.82	0.86	1.45
Other Operating Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Income	-9.73	-6.19	-0.34	-5.41	-2.95	-0.32	4.49	3.64	3.27
Unusual Expense	1.14	-0.01	-0.11	5.50	0.24	0.06	0.01	-	-
Net Income Before Taxes	-10.53	-5.77	0.06	-11.98	-2.55	-0.10	4.97	4.39	3.50
Income Taxes	-0.13	0.05	0.34	-0.67	0.27	-0.35	0.48	0.39	0.50
Consolidated Net Income	-10.40	-5.81	-0.27	-11.31	-2.82	0.24	4.46	4.00	3.00
Net Income From Continuing Operations	-10.64	-6.31	-0.64	-11.34	-2.94	0.24	4.46	4.05	3.02
Net Income	-10.64	-6.31	-0.64	-11.34	-2.94	0.24	4.46	4.05	3.02
EPS (Recurring)	-179.06	-343.66	-205.67	-4,279.09	-1,586.89	166.71	2,665.06	2,349.82	1,793.50
EPS (Basic, Before Extraordinaries)	-383.15	-343.36	-183.87	-6,479.20	-1,683.23	142.40	2,660.69	2,349.85	1,793.49
EPS (Diluted)	-383.15	-343.36	-183.87	-6,479.20	-1,683.23	142.40	2,660.69	2,349.85	1,793.49
EBITDA	-9.42	-5.87	0.09	-4.49	-2.22	0.36	4.89	3.88	3.30
Non-Operating Income (Expense)	0.34	0.41	0.29	-1.07	0.64	0.28	0.49	0.75	0.23
Other After Tax Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock Option Compensation Expense	4.27	2.93	0.09	0.11	0.13	0.16	0.13	0.12	0.01
Price To Earnings Ratio	-	-	-	-	-	2,759,000.00	141,476.51	171,884.49	-
Price To Sales Ratio	0.02	1.08	0.53	0.47	2.11	2.73	2.36	-	-
Gross Margin	35.27	42.47	56.18	43.80	44.92	57.92	65.99	68.72	65.36
Operating Margin	-147.09	-54.43	-2.15	-27.84	-20.88	-1.97	24.96	24.47	25.45
Net Margin	-160.90	-55.47	-4.05	-58.33	-20.78	1.46	24.78	27.19	23.47
Shares Outstanding	0.29	0.02	0.02	0.00	0.00	0.00	0.00	0.00	0.00
Market Capitalization	4.27	4.27	60,782.03	135,891.56	444,560.08	660,388.06	630,252.37	637,667.10	-

Income statement, quarterly

Currency USD, millions
Metric	2026S1	2025S2	2025S1	2024S2	2024S1	2023S2	2023S1	2022S2
Total Revenue	0.84	5.77	5.60	7.52	8.35	9.06	10.38	6.86
Cost of Goods Sold Incl. D&A	0.78	3.50	2.89	3.34	3.61	4.87	6.05	5.56
Gross Profit	0.06	2.28	2.71	4.18	4.74	4.19	4.32	1.30
Selling, General and Administrative Excl. Other	4.47	7.59	3.59	4.46	4.79	5.04	8.88	4.80
Research and Development	0.00	0.00	0.01	0.12	0.14	0.22	0.30	0.26
Other Operating Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Income	-4.42	-5.31	-0.88	-0.29	-0.05	-0.85	-4.56	-3.50
Unusual Expense	1.14	0.00	0.00	0.00	0.00	6.15	1.46	0.00
Net Income Before Taxes	-5.40	-5.12	-0.64	-0.01	0.08	-6.79	-5.18	-2.93
Income Taxes	0.04	-0.17	0.22	0.44	-0.11	-0.27	-0.40	-0.01
Consolidated Net Income	-5.45	-4.95	-0.86	-0.46	0.18	-6.53	-4.78	-2.92
Net Income From Continuing Operations	-5.30	-5.34	-0.97	-0.73	0.09	-6.61	-4.72	-3.03
Net Income	-5.30	-5.34	-0.97	-0.73	0.09	-6.61	-4.72	-3.03
EPS (Recurring)	-81.82	-286.78	-56.57	-234.68	50.80	-1,318.15	-2,113.17	-1,734.69
EPS (Basic, Before Extraordinaries)	-96.37	-286.78	-56.57	-234.67	50.80	-3,780.11	-2,699.23	-1,734.71
EPS (Diluted)	-96.37	-286.78	-56.57	-234.67	50.80	-3,780.11	-2,699.23	-1,734.71
EBITDA	-4.24	-5.17	-0.70	-0.09	0.18	-0.46	-4.02	-3.08
Non-Operating Income (Expense)	0.16	0.19	0.24	0.14	0.13	-1.26	0.84	0.57
Stock Option Compensation Expense	1.36	2.91	0.02	0.07	0.02	0.06	0.05	0.06
Price To Sales Ratio	0.02	1.10	2.34	0.47	0.20	0.47	1.81	2.11
Gross Margin	6.61	39.45	48.38	55.55	56.74	46.25	41.67	18.93
Operating Margin	-525.65	-92.00	-15.70	-3.84	-0.62	-9.39	-43.95	-51.01
Net Margin	-630.35	-92.57	-17.23	-9.76	1.08	-73.02	-45.50	-44.26
Shares Outstanding	0.29	0.02	0.02	0.02	0.00	0.00	0.00	0.00
Market Capitalization	4.27	17,000.41	45,469.14	60,782.03	14,834.63	135,891.56	464,454.20	444,560.08

Balance sheet, annual

Currency USD, millions
Metric	2025FY	2024FY	2023FY	2022FY	2021FY	2020FY	2019FY	2018FY	2017FY
Cash & Short Term Investments	13.92	13.08	13.45	12.04	14.21	17.11	7.83	9.08	4.80
Short Term Receivables	2.88	4.78	3.02	9.13	12.35	10.35	5.17	1.99	1.30
Inventories	0.00	0.67	1.98	1.33	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.16	0.18	0.27	0.20	0.69	1.86	0.86	1.44	0.31
Total Current Assets	16.96	18.71	18.71	22.70	27.25	29.32	13.86	12.52	6.41
Net Property, Plant & Equipment	5.90	5.96	4.02	5.56	4.13	2.06	2.14	0.67	0.05
Total Investments and Advances	1.23	1.09	1.31	1.26	2.14	1.26	0.00	0.00	0.00
Intangible Assets	0.01	0.01	0.02	6.68	0.03	0.03	0.04	0.04	0.05
Deferred Tax Assets	0.21	0.12	0.36	1.86	2.18	0.80	0.69	0.38	0.46
Other Assets	0.00	0.00	0.00	0.54	0.53	1.34	1.02	0.44	0.00
Total Assets	24.32	25.88	24.42	38.61	36.27	34.82	17.74	14.05	6.98
Short Term Debt Incl. Current Port. of LT Debt	0.03	0.03	0.24	0.48	0.09	0.06	0.21	0.73	0.00
Accounts Payable	0.53	0.54	0.68	0.14	0.04	0.41	0.12	0.02	0.58
Income Tax Payable	-	0.00	0.01	2.29	2.48	1.52	0.90	0.29	0.00
Other Current Liabilities	0.97	0.96	1.75	1.25	0.98	0.99	1.13	1.29	0.98
Total Current Liabilities	1.53	1.53	2.68	4.17	3.59	2.98	2.36	2.33	1.56
Long Term Debt	0.00	0.02	0.57	1.22	0.11	0.00	0.04	0.00	0.00
Provision for Risks Charges	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities	0.19	0.18	0.13	0.21	-	-	-	-	-
Other Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	1.72	1.73	3.38	5.60	3.70	2.98	2.40	2.33	1.56
Non-Equity Reserves	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.33	0.22
Preferred Stock - Carrying Value	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Common Equity	18.63	20.84	18.01	29.93	32.57	31.83	15.39	11.41	5.21
Total Shareholders Equity	18.63	20.84	18.01	29.93	32.57	31.83	15.39	11.41	5.21
Accumulated Minority Interest	3.97	3.31	3.03	3.09	0.00	0.00	-0.05	-0.03	-0.01
Total Equity	22.60	24.15	21.04	33.02	32.57	31.83	15.34	11.39	5.20
Total Liabilities & Stockholders Equity	24.32	25.88	24.42	38.61	36.27	34.82	17.74	14.05	6.98
Book Value Per Share	897.49	1,221.27	10,286.76	17,108.98	19,421.49	18,998.49	8,933.84	6,779.54	3,093.37
Tangible Book Value Per Share	897.12	1,220.56	10,276.74	13,290.49	19,403.44	18,977.62	8,912.17	6,753.37	3,062.63
Full-Time Employees	33	111	142	109	136	88	86	-	-
Price to Book Ratio	0.01	362.40	5,598.88	13,363.23	20,292.83	19,812.34	23,336.71	-	-
Return on Assets	-25.14	-2.56	-35.97	-7.85	0.67	16.97	25.46	28.73	-
Return on Equity	-31.98	-3.31	-47.30	-9.41	0.74	18.88	30.20	36.33	-
Return on Invested Capital	-33.87	-3.08	-61.02	-9.44	0.73	14.01	26.23	26.45	29.37
Quick Ratio	11.11	11.79	6.25	5.13	7.59	9.83	5.88	5.36	4.10
Current Ratio	11.11	12.22	6.99	5.45	7.59	9.83	5.88	5.36	4.10

Cash flow, annual

Currency USD, millions
Metric	TTM	2025FY	2024FY	2023FY	2022FY	2021FY	2020FY	2019FY	2018FY
Net Income	-10.40	-5.81	-0.27	-11.31	-2.82	0.24	4.46	4.00	3.00
Depreciation	0.31	0.32	0.43	0.92	0.71	0.68	0.40	0.24	0.03
Other Funds (Non Cash)	7.10	4.60	0.08	8.49	1.15	1.76	0.56	0.18	-0.00
Funds from Operations	-3.14	-0.97	0.53	-2.63	-0.83	1.33	5.36	4.10	3.09
Extraordinary Item	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Changes in Working Capital	0.64	1.82	-2.00	2.69	0.17	1.53	-6.40	-2.70	-1.77
Income Taxes Payable	-	0.00	-0.00	-0.10	0.00	0.91	0.54	0.62	0.30
Cash from Operating Activities	-2.50	0.85	-1.47	0.05	-0.66	2.86	-1.04	1.41	1.31
Capital Expenditures	-0.15	-0.15	-3.05	-0.84	-1.62	-1.80	-0.16	-1.31	-1.09
Net Assets From Acquisitions	0.00	0.00	0.00	0.00	-3.06	0.00	0.00	-0.03	0.00
Sale of Fixed Assets and Businesses	0.00	0.00	0.00	0.03	1.11	0.00	0.00	0.00	0.00
Purchase or Sale of Investments	-1.41	-0.67	0.96	-4.72	-0.46	0.82	-3.26	1.16	0.58
Purchase of Investments	-6.37	-9.48	-10.66	-6.32	-1.00	-0.86	-3.26	-2.46	-2.92
Sale Or Maturity of Investments	4.96	8.81	11.62	1.59	0.53	1.68	0.00	3.62	3.50
Other Uses	0.00	0.00	0.00	-0.83	-1.28	-4.11	-0.69	-0.01	0.00
Other Sources	0.00	0.00	0.28	2.61	1.95	1.08	0.01	0.00	0.00
Cash from Investing Activities	-1.57	-0.83	-1.81	-3.75	-3.35	-4.02	-4.09	-0.20	-0.50
Cash Dividends Paid	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Change in Capital Stock	4.75	0.00	3.84	0.00	1.85	0.00	11.50	-0.47	3.58
Repurchase of Common Pref Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sale of Common Pref Stock	4.75	0.00	3.84	0.00	1.85	0.00	11.50	-0.47	3.58
Proceedsfrom Stock Options	4.75	0.00	3.84	0.00	1.85	0.00	11.50	-0.47	3.58
Issuance or Reduction of Debt, Net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.72	0.76
Change in Long Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Issuance of Long Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Reduction of Long Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Net Financing Active Other Cash Flow	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Financing Activities Uses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash from Financing Activities	4.75	0.00	3.84	0.00	1.85	0.00	11.50	-1.19	4.34
Exchange Rate Effect	0.16	0.24	-0.26	-0.27	-0.24	-0.00	0.88	-0.10	-0.21
Net Change in Cash	0.83	0.26	0.29	-3.97	-2.39	-1.16	7.24	-0.09	4.94
Free Cash Flow	-2.66	0.69	-4.52	-0.79	-2.28	1.06	-1.20	0.10	0.64
Preferred Dividends (Cash Flow)	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Free Cash Flow	-	17.76	-	-	-	41.82	-	-	-
Deferred Taxes & Investment Tax Credit	-	-0.08	0.29	-0.74	0.13	-1.35	-0.06	-0.32	0.06

Balance sheet, quarterly

Currency USD, millions
Metric	2026S1	2025S2	2025S1	2024S2	2024S1	2023S2
Cash & Short Term Investments	17.34	13.92	15.03	13.08	12.22	13.45
Short Term Receivables	0.93	2.88	3.47	4.78	2.76	3.02
Inventories	0.00	0.00	0.00	0.67	1.33	1.98
Other Current Assets	0.23	0.16	0.61	0.18	0.39	0.27
Total Current Assets	18.51	16.96	19.12	18.71	16.71	18.71
Net Property, Plant & Equipment	5.82	5.90	5.92	5.96	5.78	4.02
Total Investments and Advances	1.17	1.23	1.22	1.09	1.12	1.31
Intangible Assets	-	0.01	0.01	0.01	0.01	0.02
Deferred Tax Assets	-	0.21	0.04	0.12	0.42	0.36
Other Assets	0.04	0.00	0.00	0.00	0.00	0.00
Total Assets	25.54	24.32	26.31	25.88	24.03	24.42
Short Term Debt Incl. Current Port. of LT Debt	0.00	0.03	0.03	0.03	0.22	0.24
Accounts Payable	0.21	0.53	0.95	0.54	1.23	0.68
Income Tax Payable	-	-	-	0.00	0.01	0.01
Other Current Liabilities	0.22	0.97	1.37	0.96	1.32	1.75
Total Current Liabilities	0.43	1.53	2.34	1.53	2.76	2.68
Long Term Debt	0.00	0.00	0.00	0.02	0.52	0.57
Deferred Tax Liabilities	0.04	0.19	0.21	0.18	0.03	0.13
Other Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	0.47	1.72	2.56	1.73	3.31	3.38
Non-Equity Reserves	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Stock - Carrying Value	0.00	0.00	0.00	0.00	0.00	0.00
Common Equity	21.14	18.63	20.27	20.84	17.67	18.01
Total Shareholders Equity	21.14	18.63	20.27	20.84	17.67	18.01
Accumulated Minority Interest	3.94	3.97	3.48	3.31	3.05	3.03
Total Equity	25.07	22.60	23.75	24.15	20.72	21.04
Total Liabilities & Stockholders Equity	25.54	24.32	26.31	25.88	24.03	24.42
Book Value Per Share	72.70	897.49	1,187.88	1,221.27	9,897.63	10,286.76
Tangible Book Value Per Share	72.70	897.12	1,187.30	1,220.56	9,889.40	10,276.74
Price to Book Ratio	0.01	838.77	2,193.70	362.40	2,841.21	5,598.88
Return on Assets	-41.05	-25.14	-6.75	-2.56	-23.92	-35.97
Return on Equity	-51.41	-31.98	-8.96	-3.31	-31.10	-47.30
Return on Invested Capital	-25.06	-28.69	-4.76	-3.51	0.50	-35.60
Quick Ratio	43.35	11.11	8.15	11.79	5.56	6.25
Current Ratio	43.35	11.11	8.15	12.22	6.05	6.99

Cash flow, quarterly

Currency USD, millions
Metric	2026S1	2025S2	2025S1	2024S2	2024S1	2023S2
Net Income	-5.45	-4.95	-0.86	-0.46	0.18	-6.53
Depreciation	0.17	0.14	0.18	0.20	0.23	0.39
Other Funds (Non Cash)	2.81	4.29	0.31	-0.16	0.25	6.34
Funds from Operations	-2.43	-0.71	-0.26	0.03	0.49	-0.16
Extraordinary Item	0.00	0.00	0.00	0.00	0.00	0.00
Changes in Working Capital	0.91	-0.26	2.08	-2.32	0.32	2.07
Income Taxes Payable	-	-	-	-0.00	-0.00	-0.02
Cash from Operating Activities	-1.53	-0.98	1.82	-2.28	0.81	1.91
Capital Expenditures	0.00	-0.15	0.00	-0.95	-2.10	-0.83
Net Assets From Acquisitions	0.00	0.00	0.00	0.00	0.00	0.00
Sale of Fixed Assets and Businesses	0.00	0.00	0.00	0.00	0.00	0.03
Purchase or Sale of Investments	-1.72	0.31	-0.98	0.94	0.02	-4.90
Purchase of Investments	-3.12	-3.26	-6.22	-5.24	-5.42	-5.79
Sale Or Maturity of Investments	1.40	3.56	5.24	6.18	5.44	0.90
Other Uses	0.00	0.00	0.00	0.00	0.00	-0.54
Other Sources	0.00	0.00	0.00	0.00	0.28	0.55
Cash from Investing Activities	-1.72	0.15	-0.98	-0.01	-1.80	-5.69
Cash Dividends Paid	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Dividends (Cash Flow)	0.00	0.00	0.00	0.00	0.00	0.00
Change in Capital Stock	4.75	0.00	0.00	3.84	0.00	0.00
Repurchase of Common Pref Stock	0.00	0.00	0.00	0.00	0.00	0.00
Sale of Common Pref Stock	4.75	0.00	0.00	3.84	0.00	0.00
Proceedsfrom Stock Options	4.75	0.00	0.00	3.84	0.00	0.00
Issuance or Reduction of Debt, Net	0.00	0.00	0.00	0.00	0.00	0.00
Change in Long Term Debt	0.00	0.00	0.00	0.00	0.00	0.00
Issuance of Long Term Debt	0.00	0.00	0.00	0.00	0.00	0.00
Reduction of Long Term Debt	0.00	0.00	0.00	0.00	0.00	0.00
Net Financing Active Other Cash Flow	0.00	0.00	0.00	0.00	0.00	0.00
Other Financing Activities Uses	0.00	0.00	0.00	0.00	0.00	0.00
Cash from Financing Activities	4.75	0.00	0.00	3.84	0.00	0.00
Exchange Rate Effect	0.15	0.01	0.23	0.02	-0.28	0.05
Net Change in Cash	1.65	-0.81	1.07	1.56	-1.27	-3.74
Free Cash Flow	-1.53	-1.13	1.82	-3.23	-1.29	1.08
Price to Free Cash Flow	-	18.01	-	-	-	-

Revenue breakdown

Medical Training And Education Services	2024: 7.70M 2025: 6.86M
Patient Management Services In Patientaid Projects	2024: 6.01M 2025: 3.82M
Sales Of Patented Drugs	2024: 2.15M 2025: 696.44K
China	2024: 15.86M 2025: 11.37M
MDMOOCServices	2024: 13.71M 2025: 10.68M
Sales Of Patented Drugs	2024: 2.15M 2025: 696.44K

Short interest

shares short against float, oldest to newest

Settlement	Of float	Shares short	Float	Avg volume
2026-10-30	1.34%	0.0M	3.1M	909.22K
2026-10-15	2.60%	0.1M	3.1M	2.38M
2026-09-30	4.96%	0.2M	4.3M	2.95M
2026-09-15	6.75%	0.2M	3.1M	3.22M
2026-08-31	-	0.3M	-	3.25M
2026-08-14	95.84%	0.2M	0.2M	2.90M
2026-07-31	17.08%	0.0M	0.2M	2.49M
2026-07-15	-	0.0M	-	958.13K
2026-06-30	-	0.2M	-	372.68K
2026-06-15	18.71%	0.0M	0.0M	113.84K
2026-05-29	25.60%	0.0M	0.0M	14.22K
2026-05-15	2.57%	0.0M	0.0M	94
2026-04-30	0.79%	0.0M	0.0M	1.06K
2026-04-15	1.13%	0.0M	0.0M	1.07K
2026-03-31	-	0.0M	-	1.07K
2026-03-13	-	0.0M	-	1.13K
2026-02-27	-	0.0M	-	1.09K
2026-02-13	0.84%	0.0M	0.0M	1.07K
2026-01-30	0.12%	0.0M	0.0M	95
2026-01-15	0.16%	0.0M	0.0M	107

Option chain

expiry 2026-11-11

Type	Strike	Bid	Ask	Last	IV	Open int	Volume	Delta	Theta	Vega
No option chain for this symbol.

Type

Strike

Bid

Ask

Last

Open int

Volume

Delta

Theta

Vega

No option chain for this symbol.

Latest SEC filings

Filed	Form	Description	Period	Link
2026-10-30	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16	2026-06-30	SEC
2026-09-21	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16	2026-09-21	SEC
2026-09-11	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16	2026-09-11	SEC
2026-08-14	SCHEDULE 13G/A			SEC
2026-08-11	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16	2026-08-11	SEC
2026-08-06	424B5			SEC
2026-07-28	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16	2026-07-27	SEC
2026-07-24	424B5			SEC
2026-07-22	SCHEDULE 13D/A			SEC
2026-07-22	4	Statement of changes in beneficial ownership of securities	2026-07-21	SEC
2026-07-22	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16	2026-07-22	SEC
2026-06-23	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16	2026-06-23	SEC
2026-06-09	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16	2026-06-09	SEC
2026-06-09	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16	2026-06-09	SEC
2026-06-05	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16	2026-06-05	SEC
2026-06-05	SCHEDULE 13G			SEC
2026-06-01	424B4			SEC
2026-05-28	EFFECT	Effectiveness filing by commission order		SEC
2026-05-26	CORRESP			SEC
2026-05-26	CORRESP			SEC
2026-05-22	F-1/A			SEC
2026-05-07	F-1	Registration statement for certain foreign private issuers		SEC
2026-04-03	20-F	Registration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.	2025-12-31	SEC
2026-03-25	3	Initial statement of beneficial ownership of securities	2026-03-18	SEC
2026-03-20	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16	2026-03-20	SEC
2026-03-19	3	Initial statement of beneficial ownership of securities	2026-03-18	SEC
2026-03-18	3	Initial statement of beneficial ownership of securities	2026-03-18	SEC
2026-03-18	3	Initial statement of beneficial ownership of securities	2026-03-18	SEC
2026-03-18	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16	2026-03-18	SEC
2026-03-18	3	Initial statement of beneficial ownership of securities	2026-03-18	SEC

Insider activity by month

Month	Bought	Buys	Sold	Sells
2026-11	0	0	0	0
2026-10	0	0	0	0
2026-09	0	0	0	0
2026-08	0	0	0	0
2026-07	0	0	0	0
2026-06	0	0	0	0
2026-05	0	0	0	0
2026-04	0	0	0	0
2026-03	0	0	0	0
2026-02	0	0	0	0
2026-01	0	0	0	0
2025-12	0	0	0	0
2025-11	0	0	0	0

Institutional holders

Manager	% owned
LPL Financial LLC	0.25%
UBS Group AG	0.02%

Manager

% owned

LPL Financial LLC

0.25%

UBS Group AG

0.02%

Funds

Fund	% owned
Fidelity Nasdaq Composite Index Fund	0.00%

Fund

% owned

Fidelity Nasdaq Composite Index Fund

0.00%

OakChart. ZCMD. Cached 15 minutes.

Some panels did not load: ratings, insider.